MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas.

Brain Pathol 2015 Jul 20;25(4):491-504. Epub 2014 Nov 20.

Edinger Institute, Institute of Neurology, Goethe University Frankfurt, Frankfurt am Main, Germany.

The macrophage migration inhibitory factor (MIF) receptor CD74 is overexpressed in various neoplasms, mainly in hematologic tumors, and currently investigated in clinical studies. CD74 is quickly internalized and recycles after antibody binding, therefore it constitutes an attractive target for antibody-based treatment strategies. CD74 has been further described as one of the most up-regulated molecules in human glioblastomas. To assess the potential relevance for anti-CD74 treatment, we determined the cellular source and clinicopathologic relevance of CD74 expression in human gliomas by immunohistochemistry, immunofluorescence, immunoblotting, cell sorting analysis and quantitative polymerase chain reaction (qPCR). Furthermore, we fractionated glioblastoma cells and glioma-associated microglia/macrophages (GAMs) from primary tumors and compared CD74 expression in cellular fractions with whole tumor lysates. Our results show that CD74 is restricted to GAMs in vivo, while being absent in tumor cells, the latter strongly expressing its ligand MIF. Most interestingly, a higher amount of CD74-positive GAMs was associated with beneficial patient survival constituting an independent prognostic parameter and with an anti-tumoral M1 polarization. In summary, CD74 expression in human gliomas is restricted to GAMs and positively associated with patient survival. In conclusion, CD74 represents a positive prognostic marker most probably because of its association with an M1-polarized immune milieu in high-grade gliomas.

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bpa.12194
Publisher Site
http://dx.doi.org/10.1111/bpa.12194DOI Listing
July 2015
113 Reads

Publication Analysis

Top Keywords

cd74 expression
12
patient survival
12
cd74
9
mif receptor
8
human gliomas
8
expression human
8
immune milieu
8
receptor cd74
8
m1-polarized immune
8
cd74 restricted
8
gliomas immunohistochemistry
4
relevance cd74
4
clinicopathologic relevance
4
immunohistochemistry immunofluorescence
4
immunofluorescence immunoblotting
4
sorting analysis
4
beneficial patient
4
analysis quantitative
4
cell sorting
4
survival constituting
4

References

(Supplied by CrossRef)
Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege
Apte et al.
J Immunol 1998
Milatuzumab-a promising new immunotherapeutic agent
Berkova et al.
Expert Opin Investig Drugs 2010
Regulation of inflammation- and angiogenesis-related gene expression in breast cancer cells and co-cultured macrophages
Burnett et al.
Anticancer Res 2008

Similar Publications